[1]
L. V. Sampaio et al., “CLINICAL USE OF GLP-1 ANALOGUES IN THE TREATMENT OF T2DM AND OBESITY: WHAT STAGE ARE WE AT?”, REASE, vol. 10, no. 9, pp. 742–750, Sep. 2024, doi: 10.51891/rease.v10i9.15519.